Advisory Research’s Super Group (SGHC) Limited Redeemable Warrants, each whole Warrant exercisable for one Ordinary Share, each at an exercise price of $11. 50 per share SGHC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-16,719
Closed -$10K 425
2022
Q2
$10K Buy
+16,719
New +$28.5K ﹤0.01% 351

Other funds holding SGHC.WS

Advisory Research's SGHC.WS Position: Q3 2022 in Review

Advisory Research sold out of Super Group (SGHC) Limited Redeemable Warrants, each whole Warrant exercisable for one Ordinary Share, each at an exercise price of $11. 50 per share (SGHC.WS) in Q3 2022, closing a stake of 16,719 shares — an estimated $10K sold.

Advisory Research first reported a position in SGHC.WS in Q2 2022 and held it in 1 quarter. The position peaked at $10K in Q2 2022. 17 funds tracked by Wall St. Rank hold SGHC.WS as of Q3 2022.

  • Advisory Research reported no remaining Super Group (SGHC) Limited Redeemable Warrants, each whole Warrant exercisable for one Ordinary Share, each at an exercise price of $11. 50 per share position as of Q3 2022 after selling out during the quarter.
  • Advisory Research sold 16,719 Super Group (SGHC) Limited Redeemable Warrants, each whole Warrant exercisable for one Ordinary Share, each at an exercise price of $11. 50 per share shares in Q3 2022, an estimated $10K.
  • Advisory Research first reported a position in Super Group (SGHC) Limited Redeemable Warrants, each whole Warrant exercisable for one Ordinary Share, each at an exercise price of $11. 50 per share in Q2 2022 and held it in 1 quarter.
  • Advisory Research's Super Group (SGHC) Limited Redeemable Warrants, each whole Warrant exercisable for one Ordinary Share, each at an exercise price of $11. 50 per share position peaked at $10K in Q2 2022.
  • 17 funds tracked by Wall St. Rank held Super Group (SGHC) Limited Redeemable Warrants, each whole Warrant exercisable for one Ordinary Share, each at an exercise price of $11. 50 per share as of Q3 2022.

Based on Advisory Research's 13F filing for Q3 2022, filed 15 Nov 2022.